IM

IMCD NVAMS IMCD Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

9.967

Middle

Exchange

XAMS - Euronext Amsterdam

IMCD.AS Stock Analysis

IM

Neutral

Based on Eyestock quantitative analysis, IMCD.AS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

56/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

9.9 %

Undervalued

Market cap $B

9.967

Dividend yield

1.52 %

Shares outstanding

56.887 B

IMCD NV engages in the sale, marketing, and distribution of specialty chemicals and ingredients. The company is headquartered in Rotterdam, Zuid-Holland and currently employs 4,323 full-time employees. The company went IPO on 2014-06-27. Its product portfolio includes chemicals from various areas, including pharmaceutics, personal care, coatings, food and nutrition, lubricants, synthesis, plastics, detergents, agrochemicals, textile, waste and water treatment, cutting and sand blasting, flavors and fragrances, oil and gas and polishing, among others. The firm operates an international supply chain with local warehouses and provides valued-added services, including repacking, dilution and blending. The firm operates worldwide.

View Section: Eyestock Rating